CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

lifesci partners coverage, page-2

  1. 379 Posts.
    lightbulb Created with Sketch. 2
    thanks for posting that link. good to read more positive coverage of Chemgenex.

    SP is slowly moving up again.

    maybe presentation at Rodman and Renshaw conference has done the trick.

    Investors could be taking positions before submission of new NDA before year end, and presentation at ASH 2010.

    I don't see any other news coming in the near term (unless we see a resolution on the issue of T315I mutation diagnostic test of course!)
 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.